HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

pasireotide

Also Known As:
SOM 230; SOM-230; SOM230; cyclo((4R)-4-(2-aminoethylcarbamoyloxy)-L-prolyl-L-phenylglycyl-d-tryptophyl-L-lysyl-4-o-benzyl-L-tyrosyl-L-phenylalanyl-)
Networked: 421 relevant articles (88 outcomes, 140 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Colao, Annamaria: 24 articles (06/2020 - 05/2007)
2. Fleseriu, Maria: 20 articles (03/2022 - 01/2013)
3. Schmid, Herbert A: 20 articles (01/2022 - 01/2004)
4. Pivonello, Rosario: 16 articles (06/2020 - 05/2007)
5. Shimon, Ilan: 14 articles (10/2022 - 12/2012)
6. Hu, Ke: 13 articles (01/2018 - 01/2012)
7. Petersenn, Stephan: 12 articles (02/2020 - 05/2010)
8. Boscaro, Marco: 12 articles (01/2019 - 05/2009)
9. Hofland, Leo J: 11 articles (06/2020 - 01/2004)
10. De Marinis, Laura: 10 articles (02/2021 - 03/2007)

Related Diseases

1. Acromegaly
2. Pituitary ACTH Hypersecretion
3. Neoplasms (Cancer)
4. Hyperglycemia
5. Cushing Syndrome

Related Drugs and Biologics

1. Somatostatin (Somatotropin Release-Inhibiting Factor)
2. Octreotide (Sandostatin)
3. Somatostatin Receptors (Somatostatin Receptor)
4. pasireotide
5. Ligands
6. Adrenocorticotropic Hormone (ACTH)
7. lanreotide (Somatuline)
8. Cabergoline
9. Everolimus
10. Hydrocortisone (Cortisol)

Related Therapies and Procedures

1. Therapeutics
2. Pancreatectomy
3. Drug Therapy (Chemotherapy)
4. Sclerotherapy
5. Glycemic Control